IL148457A0 - Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells - Google Patents
Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cellsInfo
- Publication number
- IL148457A0 IL148457A0 IL14845700A IL14845700A IL148457A0 IL 148457 A0 IL148457 A0 IL 148457A0 IL 14845700 A IL14845700 A IL 14845700A IL 14845700 A IL14845700 A IL 14845700A IL 148457 A0 IL148457 A0 IL 148457A0
- Authority
- IL
- Israel
- Prior art keywords
- span
- extension
- somatic cells
- cell life
- telomere
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15234099P | 1999-09-07 | 1999-09-07 | |
US17948600P | 2000-02-01 | 2000-02-01 | |
US52702600A | 2000-03-16 | 2000-03-16 | |
US52087900A | 2000-04-05 | 2000-04-05 | |
PCT/US2000/024393 WO2001018236A1 (en) | 1999-09-07 | 2000-09-06 | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
Publications (1)
Publication Number | Publication Date |
---|---|
IL148457A0 true IL148457A0 (en) | 2002-09-12 |
Family
ID=27496015
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14845700A IL148457A0 (en) | 1999-09-07 | 2000-09-06 | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
IL148457A IL148457A (en) | 1999-09-07 | 2002-02-28 | Method of isolating a mammalian primary cell of a desired type, a cell isolated by the method and a tissue isolated by the method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL148457A IL148457A (en) | 1999-09-07 | 2002-02-28 | Method of isolating a mammalian primary cell of a desired type, a cell isolated by the method and a tissue isolated by the method |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1214443A4 (en) |
JP (1) | JP2003508079A (en) |
CN (1) | CN1377424A (en) |
AU (1) | AU7350800A (en) |
BR (1) | BR0013844A (en) |
CA (1) | CA2383790C (en) |
IL (2) | IL148457A0 (en) |
MX (1) | MXPA02002443A (en) |
NZ (1) | NZ531844A (en) |
WO (1) | WO2001018236A1 (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0011905A (en) * | 1999-09-07 | 2003-07-08 | Advanced Cell Tech Inc | Process for generating immunocompatible cells and tissues using nuclear transfer techniques |
US8521440B2 (en) | 2007-01-08 | 2013-08-27 | The Invention Science Fund I, Llc | Systems for genome selection |
US7709244B2 (en) | 2007-01-08 | 2010-05-04 | The Invention Science Fund I, Llc | Systems for genome selection |
US7947455B2 (en) | 2007-01-08 | 2011-05-24 | The Invention Science Fund I, Llc | System for genome selection |
US8012740B2 (en) | 2007-01-08 | 2011-09-06 | The Invention Science Fund I, Llc | Systems for genome selection |
US7713728B2 (en) | 2007-01-08 | 2010-05-11 | The Invention Sciencefund I, Llc | Systems for genome selection |
US8003371B2 (en) | 2007-01-08 | 2011-08-23 | The Invention Science Fund I, Llc | Systems for genome selection |
US7947457B2 (en) | 2007-01-08 | 2011-05-24 | The Invention Science Fund I, Llc | Systems for genome selection |
US7709245B2 (en) | 2007-01-08 | 2010-05-04 | The Invention Science Fund I, Llc | Systems for genome selection |
US7718418B2 (en) | 2007-01-08 | 2010-05-18 | The Invention Science Fund I, Llc | Systems for genome selection |
US7985578B2 (en) | 2007-01-08 | 2011-07-26 | The Invention Science Fund I, Llc | Systems for genome selection |
US7648823B2 (en) | 2007-01-08 | 2010-01-19 | Searete Llc | Systems for genome selection |
MX2010012089A (en) * | 2008-05-06 | 2011-07-28 | Advanced Cell Tech Inc | Methods for producing enucleated erythroid cells derived from pluripotent stem cells. |
JP5888852B2 (en) * | 2010-12-08 | 2016-03-22 | 学校法人近畿大学 | Cell production using immunodeficient animals |
ES2695550T3 (en) * | 2011-04-08 | 2019-01-09 | Inst Nat Sante Rech Med | Method to rejuvenate cells |
HUE054946T2 (en) | 2015-03-23 | 2021-10-28 | Astellas Inst For Regenerative Medicine | Improved assays for potency of human retinal pigment epithelium (rpe) cells and photoreceptor progenitors |
KR20210057024A (en) * | 2018-09-06 | 2021-05-20 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | Telomerase complete enzyme complex and method of use thereof |
WO2023224556A1 (en) * | 2022-05-17 | 2023-11-23 | National University Of Singapore | Chimeric ovarian follicle-based therapy to treat female infertility |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
US5648215A (en) * | 1992-05-13 | 1997-07-15 | Board Of Regents, The University Of Texas System | Telomerase diagnostic methods |
US5945577A (en) * | 1997-01-10 | 1999-08-31 | University Of Massachusetts As Represented By Its Amherst Campus | Cloning using donor nuclei from proliferating somatic cells |
JP2002512510A (en) * | 1997-03-06 | 2002-04-23 | インフィジェン・インコーポレーテッド | Animal cloning method |
GB9809178D0 (en) * | 1998-04-29 | 1998-07-01 | Univ Edinburgh | Nuclear reprogramming of somatic cells |
JP2003503071A (en) * | 1999-06-30 | 2003-01-28 | アドバンスド セル テクノロジー、インコーポレイテッド | Cytoplasmic transfer to dedifferentiated recipient cells |
BR0011905A (en) * | 1999-09-07 | 2003-07-08 | Advanced Cell Tech Inc | Process for generating immunocompatible cells and tissues using nuclear transfer techniques |
-
2000
- 2000-09-06 NZ NZ531844A patent/NZ531844A/en not_active IP Right Cessation
- 2000-09-06 MX MXPA02002443A patent/MXPA02002443A/en not_active Application Discontinuation
- 2000-09-06 CA CA2383790A patent/CA2383790C/en not_active Expired - Lifetime
- 2000-09-06 CN CN00813712A patent/CN1377424A/en active Pending
- 2000-09-06 BR BR0013844-4A patent/BR0013844A/en not_active Application Discontinuation
- 2000-09-06 AU AU73508/00A patent/AU7350800A/en not_active Abandoned
- 2000-09-06 EP EP00961569A patent/EP1214443A4/en not_active Ceased
- 2000-09-06 JP JP2001521771A patent/JP2003508079A/en active Pending
- 2000-09-06 WO PCT/US2000/024393 patent/WO2001018236A1/en active Application Filing
- 2000-09-06 IL IL14845700A patent/IL148457A0/en unknown
-
2002
- 2002-02-28 IL IL148457A patent/IL148457A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN1377424A (en) | 2002-10-30 |
MXPA02002443A (en) | 2004-07-16 |
JP2003508079A (en) | 2003-03-04 |
NZ531844A (en) | 2005-08-26 |
BR0013844A (en) | 2002-05-14 |
IL148457A (en) | 2013-01-31 |
CA2383790C (en) | 2016-11-22 |
EP1214443A1 (en) | 2002-06-19 |
EP1214443A4 (en) | 2003-08-27 |
AU7350800A (en) | 2001-04-10 |
WO2001018236A1 (en) | 2001-03-15 |
CA2383790A1 (en) | 2001-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL148457A0 (en) | Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells | |
GB2364059B (en) | Beta-Secretase enzyme compositions and methods | |
IL144359A0 (en) | Immortalized cell lines and methods of making the same | |
IL137946A0 (en) | Intracardiac cell delivery and cell transplantation | |
HUP0201887A2 (en) | Conditioned cell culture medium compositions and methods of use | |
IL145002A0 (en) | Adipose-derived stem cells and lattices | |
HK1081225A1 (en) | Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same | |
EP0885308A4 (en) | Compositions and methods of making embryonic stem cells | |
IL125532A0 (en) | Hematopoietic cell composition for use in transplantation | |
NZ513967A (en) | Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists | |
NO20004856D0 (en) | Gel electrolyte and gel electrolyte cell | |
EP1238059A4 (en) | Long-term cell culture compositions and genetically modified animals derived therefrom | |
EP1185555A4 (en) | Compositions isolated from skin cells and methods for their use | |
AU2003296432A8 (en) | Methods and compositions for inhibiting the growth of hematopoietic malignant cells | |
GB9809178D0 (en) | Nuclear reprogramming of somatic cells | |
EP1163334A4 (en) | Polynucleotide and deduced amino acid sequences from stromal cells | |
GB9900398D0 (en) | Arrangements of electrochemical cells | |
EP1088055A4 (en) | Allelic series of genomic modifications in cells | |
EP1218393A4 (en) | Cell targeting compositions and methods of using the same | |
AU2998300A (en) | Genetically altered mesenchymal stem cells and methods of use thereof | |
HUP0501094A2 (en) | Somatic cell derived embryonic stem cells and its differentiated cells | |
GB0318113D0 (en) | ›-Secretase enzyme compositions and methods | |
AU4774200A (en) | Long term cell culture of human carcinoma | |
PL371542A1 (en) | Somatic cell derived embryonic stem cells and its differentiated cells | |
AU2002221468A1 (en) | Somatic cell derived embryonic stem cells and its differentiated cells |